Claims
- 1. A pharmaceutical comprising, in combination, a resinate and an aversive agent.
- 2. The pharmaceutical of claim 1 in which said resinate comprises an ion exchange resin and an drug.
- 3. The pharmaceutical of claim 2 in which said aversive agent is selected from the group consisting of capsaicin, capsico, capsacutin, dihydrocapsaicin, nordihydrocapsaicin, homocapsaicin, homodihydrocapsaicin, capsaicinoids, gingerol, chemical mace, piperine, isochavicine, isopiperine, piperidine, chavicine, piperettine, zingerone, shogaol, valleral, an isovalleral, vanyllylamide, nonoyl vanyllamide, a vanyllylamide derivative, a synthetic derivative of a capsaicinoids, and a powder of: a Capsicum frutescens variety, a Capsicum anuum variety, a Capsicum chinense variety, a Capsicum baccatum variety, a Capsicum pubescens variety, a Capsicum species, a Piper migrum variety, a Piper longum variety, a Piper retrofractum variety, a Piper officinarum variety, a Piperaceae species, a Brassica juncea variety, a Brassica. nigra variety, a Sinapis alba variety, a Sinapis arvensis variety, a Zingiber officinale variety, and a Lactarius vellereus variety, and a mixture thereof.
- 4. The pharmaceutical of claim 2 in which said drug is a controlled substance.
- 5. The pharmaceutical of claim 4 in which both said aversive agent and said controlled substance are loaded onto said ion exchange resin.
- 6. The pharmaceutical of claim 4 in which said aversive agent is loaded onto said ion exchange resin, and said controlled substance is not loaded onto said ion exchange resin.
- 7. The pharmaceutical of claim 4 in which said controlled substance is loaded onto said ion exchange resin, and said aversive agent is not loaded onto said ion exchange resin.
- 8. The pharmaceutical of claim 4 in which said controlled substance is loaded onto a first ion exchange resin, and said aversive agent is loaded onto an ion exchange resin different from said first ion exchange resin.
- 9. The pharmaceutical of claim 1 in a form that is readily ingestible.
- 10. The pharmaceutical of claim 1 in the form of a tablet or capsule.
Parent Case Info
[0001] This application claims benefit to U.S. patent application Ser. No. 10/016,336, filed Nov. 2, 2001, entitled: “Dosage Forms.”
Provisional Applications (1)
|
Number |
Date |
Country |
|
60322624 |
Sep 2001 |
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
10016336 |
Nov 2001 |
US |
Child |
10679785 |
Oct 2003 |
US |